(R)-6-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride is primarily utilized in pharmaceutical research and development as a chiral building block. It serves as a key intermediate in the synthesis of various bioactive compounds, particularly those targeting the central nervous system. Its stereochemistry makes it valuable for creating enantiomerically pure drugs, which can enhance efficacy and reduce side effects. The compound is often explored in the development of potential treatments for neurological disorders, such as depression, anxiety, and Parkinson's disease. Additionally, it is used in medicinal chemistry studies to investigate receptor interactions and optimize drug candidates for improved pharmacokinetic properties.